These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32470386)

  • 21. Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets.
    Vieira MNN; Lima-Filho RAS; De Felice FG
    Neuropharmacology; 2018 Jul; 136(Pt B):160-171. PubMed ID: 29129775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?
    Pivovarova O; Höhn A; Grune T; Pfeiffer AF; Rudovich N
    Ann Med; 2016 Dec; 48(8):614-624. PubMed ID: 27320287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of risk factors for depression in Alzheimer's disease patients.
    Yang H; Hong W; Chen L; Tao Y; Peng Z; Zhou H
    Int J Neurosci; 2020 Nov; 130(11):1136-1141. PubMed ID: 32053409
    [No Abstract]   [Full Text] [Related]  

  • 24. Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications.
    Tumminia A; Vinciguerra F; Parisi M; Frittitta L
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30355995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's and type 2 diabetes treatment via common enzyme targeting.
    Jabir NR; Kamal MA; Abuzenadah AM; Gan SH; Alama MN; Baeesa SS; Tabrez S
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):299-304. PubMed ID: 24059315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in Glucose Metabolism in Alzheimer's Disease.
    Calsolaro V; Edison P
    Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):31-39. PubMed ID: 27306508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
    Li X; Song D; Leng SX
    Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic links between diabetes and Alzheimer's disease.
    Maher PA; Schubert DR
    Expert Rev Neurother; 2009 May; 9(5):617-30. PubMed ID: 19402773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Action of Polyphenols in Diabetes Mellitus and Alzheimer's Disease: A Common Agent for Overlapping Pathologies.
    Silveira AC; Dias JP; Santos VM; Oliveira PF; Alves MG; Rato L; Silva BM
    Curr Neuropharmacol; 2019; 17(7):590-613. PubMed ID: 30081787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
    Mushtaq G; Greig NH; Khan JA; Kamal MA
    CNS Neurol Disord Drug Targets; 2014; 13(8):1432-9. PubMed ID: 25345511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-hyperglycemic and anti-hyperlipidemic effects of a special fraction of Luohanguo extract on obese T2DM rats.
    Zhang Y; Zhou G; Peng Y; Wang M; Li X
    J Ethnopharmacol; 2020 Jan; 247():112273. PubMed ID: 31586692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glucagon-like peptide 1: a novel therapeutic strategy for Alzheimer's disease].
    Wang XH; Yang W; Qi JS
    Sheng Li Xue Bao; 2010 Oct; 62(5):398-406. PubMed ID: 20945041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.
    Ashraf GM; DasGupta D; Alam MZ; Baeesa SS; Alghamdi BS; Anwar F; Alqurashi TMA; Sharaf SE; Al Abdulmonem W; Alyousef MA; Alhumaydhi FA; Shamsi A
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focusing on the Link between Diabetes, Alzheimer's Disease and Cancer for the Discovery of New Medicines.
    Yang X; Wang K
    Curr Top Med Chem; 2016; 16(7):675-6. PubMed ID: 26381416
    [No Abstract]   [Full Text] [Related]  

  • 35. Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders.
    Shaikh S; Rizvi SM; Shakil S; Riyaz S; Biswas D; Jahan R
    Biotechnol Appl Biochem; 2016; 63(1):145-50. PubMed ID: 25402624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humanin: a possible linkage between Alzheimer's disease and type 2 diabetes.
    Mahboobi H; Golmirzaei J; Gan SH; Jalalian M; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):543-52. PubMed ID: 24365186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
    Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
    Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 2 Diabetes Mellitus and Alzheimer's Disease: Bridging the Pathophysiology and Management.
    Alam F; Islam MA; Sasongko TH; Gan SH
    Curr Pharm Des; 2016; 22(28):4430-42. PubMed ID: 27229721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus.
    Rani L; Grewal AS; Sharma N; Singh S
    Mini Rev Med Chem; 2021; 21(4):426-470. PubMed ID: 33100202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
    Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
    Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.